Leukemia - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Milk Thistle Extract for Chemotherapy-Induced Liver Toxicity
(Posted: 10/04/2005) - In this trial, researchers are testing the ability of a nutritional supplement called silymarin to treat liver damage caused by chemotherapy for childhood acute lymphoblastic leukemia.
- Targeted Monoclonal Antibody Therapy for a Rare T-Cell Leukemia
(Posted: 09/06/2005) - This study will assess the safety of MiK-beta-1, a monoclonal antibody, in patients with T-cell large granular lymphocyte leukemia (T-LGLL). If the treatment is tolerated, it may eventually be used to treat not only T-LGLL, but also certain autoimmune disorders such as rheumatoid arthritis and multiple sclerosis.
- Outpatient Treatment for Older Patients with AML
(Posted: 06/28/2005) - In this study, researchers are testing a new drug called tipifarnib (Zarnestra) to treat patients aged 70 or older who have AML and who are not eligible for standard treatment. Tipifarnib is an oral medication that allows patients with AML to be treated in an outpatient setting.
- Targeting Progressive Chronic Lymphocytic Leukemia
(Posted: 06/14/2005) - In this study, researchers are testing the effectiveness of an immunotoxin called LMB-2 in selectively killing chronic lymphocytic leukemia (CLL) cells. LMB-2 binds to a protein called CD25 and delivers a bacterial toxin that may kill the cells.
- Preventing Graft-versus-Host Disease during Hematologic Cancer Treatment
(Posted: 05/31/2005) - Researchers are investigating whether an immunosuppressive drug, sirolimus, can work with cyclosporine to prevent graft-versus-host disease (GVHD) more effectively than cyclosporine alone following allogeneic hematopoietic stem cell transplantation.